Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Lupin Gets FDA Final Nod to Market Generic Seasonale Tablets
Oct. 26, 2012
Lupin Pharmaceuticals received final approval for its levonorgestrel and ethinyl estradiol tablets, USP 0.15 mg/0.03 mg, from the FDA to market a generic version of Teva Pharmaceuticals’ Seasonale tablets.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing